Publicacións en colaboración con investigadores/as de Universidade da Coruña (63)

2024

  1. Real-life effectiveness of sofosbuvir/velpatasvir/voxilaprevir in hepatitis C patients previously treated with sofosbuvir/velpatasvir or glecaprevir/pibrentasvir

    Alimentary Pharmacology and Therapeutics

2023

  1. Brief Training of Technical Bleeding Control Skills—A Pilot Study with Security Forces

    International Journal of Environmental Research and Public Health, Vol. 20, Núm. 3

  2. Cognitive impairment and dementia in young onset Parkinson’s disease

    Journal of Neurology, Vol. 270, Núm. 12, pp. 5793-5812

  3. Overexpression of E-Cadherin Is a Favorable Prognostic Biomarker in Oral Squamous Cell Carcinoma: A Systematic Review and Meta-Analysis

    Biology, Vol. 12, Núm. 2

  4. Predictive value of CDKN2A/p16INK4a expression in the malignant transformation of oral potentially malignant disorders: Systematic review and meta-analysis

    Pathology Research and Practice, Vol. 248

  5. The interaction between liver cirrhosis, infection by Streptococcus bovis, and colon cancer

    European Journal of Clinical Microbiology and Infectious Diseases, Vol. 42, Núm. 7, pp. 907-912

2022

  1. Biologic therapy in refractory neurobehçet's disease: a multicentre study of 41 patients and literature review

    Rheumatology (Oxford, England), Vol. 61, Núm. 11, pp. 4427-4436

  2. Correction: Chaparro et al. Incidence, Clinical Characteristics and Management of Inflammatory Bowel Disease in Spain: Large-Scale Epidemiological Study (J. Clin. Med., (2021), 10, (2885), 10.3390/jcm10132885)

    Journal of Clinical Medicine

  3. Evaluation of contingency plans in the care of patients in intensive care units in the COVID-19 pandemic

    Journal of Healthcare Quality Research, Vol. 37, Núm. 5, pp. 291-298

  4. Impact of the COVID-19 pandemic in the lipid control of the patients that start PCSK9 inhibitors

    Clinica e Investigacion en Arteriosclerosis, Vol. 34, Núm. 5, pp. 245-252

  5. Long-Term Real-World Effectiveness and Safety of Ustekinumab in Crohn's Disease Patients: The SUSTAIN Study

    Inflammatory bowel diseases, Vol. 28, Núm. 11, pp. 1725-1736

  6. Motor Fluctuations Development Is Associated with Non-Mostor Symptoms Burden Progression in Parkinson’s Disease Patients: A 2-Year Follow-Up Study

    Diagnostics, Vol. 12, Núm. 5

  7. Non-pharmacologic direct cost of a simplified strategy with glecaprevir/pibrentasvir for 8 weeks in naïve non-cirrhotic patients with hepatitis C implemented in clinical practice. The Just SIMPLE Study

    Gastroenterologia y Hepatologia, Vol. 45, Núm. 5, pp. 342-349

  8. Oral Chronic Hyperplastic Candidiasis and Its Potential Risk of Malignant Transformation: A Systematic Review and Prevalence Meta-Analysis

    Journal of Fungi, Vol. 8, Núm. 10

  9. Survival outcomes in laryngeal chondrosarcoma: a systematic review

    Acta Otorhinolaryngologica Italica, Vol. 42, Núm. 6, pp. 502-515

  10. Using Interpretable Machine Learning to Identify Baseline Predictive Factors of Remission and Drug Durability in Crohn’s Disease Patients on Ustekinumab

    Journal of Clinical Medicine, Vol. 11, Núm. 15

  11. Vortioxetine Improves Depressive Symptoms and Cognition in Parkinson’s Disease Patients with Major Depression: An Open-Label Prospective Study

    Brain Sciences, Vol. 12, Núm. 11

2021

  1. COVID-19 pneumonia in Galicia (Spain): Impact of prognostic factors and therapies on mortality and need for mechanical ventilation

    PLoS ONE, Vol. 16, Núm. 6 June

  2. Cutaneous adverse events in patients receiving anticancer therapy in a tertiary hospital setting: the old and the new

    International Journal of Dermatology, Vol. 60, Núm. 2, pp. 208-216

  3. Depression is Associated with Impulse-compulsive Behaviors in Parkinson's disease: Impulse-compulsive Behaviors and Depression in PD

    Journal of Affective Disorders, Vol. 280, pp. 77-89